Skip to main content
Log in

The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts

  • Calcium Antagonists
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Ro 40-5967 is a structurally novel Ca2+ channel blocker that binds to the verapamil-type receptor of cardiac membranes but that has been shown in isolated guinea-pig hearts to be about ten times less potent a negative inotropic agent than verapamil. The goals of the present study were to confirm these findings in vitro in isolated perfused rat hearts as well as in vivo in conscious rats and to compare Ro 40-5967 to verapamil. The effects of Ro 40-5967 and verapamil were tested not only in normal rats, but also in rats with heart failure induced by chronic myocardial infarction. In isolated Langendorff hearts (without heart failure), no decrease of contractility was observed with Ro 40-5967 up to complete AV block. In contrast, verapamil decreased contractility with an IC50 of 100 nM. In isolated, electrically stimulated rat papillary muscles, the IC50 values for the decrease of contractile force were 15,000 and 440 nM for Ro 40-5967 and verapamil, respectively. In vivo, Ro 40-5967 did not decrease left ventricular contractility (as assessed by changes of dP/dt max+) in rats without and with heart failure. In contrast, verapamil was markedly negative inotropic in both conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Osterrieder W, Holck M. In vitro pharmacological profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.J Cardiovasc Pharmacol 1989;13:754–759.

    PubMed  Google Scholar 

  2. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction.New Engl J Med 1988;319:385–392.

    Google Scholar 

  3. Selye H, Bajusz E, Grassos S, et al. Simple techniques for the surgical occlusion of coronary vessels in the rat.Angiology 1960;11:398–407.

    PubMed  Google Scholar 

  4. Sarnoff SJ, Mitchell JH.Control of the function of the heart, Handbook of physiology, section 2, vol. I, 1962.

  5. Ross J. Jr, Covell JW, Sonnenblick EH, et al.. Contractile state of heart characterized by force-velocity relations in variably afterloaded and isovolumic beats.Circ Res 1966; 18:149–163.

    Google Scholar 

  6. Clancy RL, Graham TP, Ross J, et al. Influence of aortic pressure-induced homeometric autoregulation on myocardial performance.Am J Physiol 1968;214:1186–1192.

    PubMed  Google Scholar 

  7. Wallace AG, Skinner NS Jr, Mitchell JH. Hemodynamic determinants of the maximal rate of left ventricular pressure.Am J Physiol 1963;205:30–36.

    PubMed  Google Scholar 

  8. Furnival CM, Linden RJ, Snow HM. Inotropic changes in the left ventricle. The effect of changes in heart rate aortic pressure and end-diastolic pressure.J Physiol 1970;211:359–387.

    PubMed  Google Scholar 

  9. Quinones MA, Gaasch WH, Alexander JK. Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man.Circulation 1976;53:293–302.

    PubMed  Google Scholar 

  10. Little WC. The left ventricular dP/dt max+and diastolic volume relation in closed-chest dogs.Circ Res 1985;56:808–815.

    PubMed  Google Scholar 

  11. Cohen L, Vereault D, Wasserstrom JA, et al. Evidence that uncharged verapamil inhibits myocardial contractility.J Pharmacol Exp Ther 1987;242:721–725.

    PubMed  Google Scholar 

  12. Ferry DR, Glossmann H, Kaumann AJ. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart.Br J Pharmacol 1985;84:811–824.

    PubMed  Google Scholar 

  13. Packer M, Kessler PD, Lee WH. Calcium-channel blockade in the management of severe chronic congestive heart failure: A bridge too far.Circulation 1987;75(Suppl V):V56-V64.

    PubMed  Google Scholar 

  14. Briscoe MG, Smith HJ. Sensitivity of cat papillary muscles to verapamil and nifedipine: Enhanced effect in acidosis.Cardiovasc Res 1982;16:173–177.

    PubMed  Google Scholar 

  15. Konishi T, Nakamura Y, Konishi T, et al. Accentuated negative inotropism of verapamil after ischaemic intervention in isolated working rat heart.Cardiovasc Res 1984;18:639–644.

    PubMed  Google Scholar 

  16. Smith HJ, Goldstein RA, Griffith JM, et al. Regional contractility: Selective depression of ischemic myocardium by verapamil.Circulation 1976;54:629–635.

    PubMed  Google Scholar 

  17. Chew CYC, Hecht HS, Collett JT, et al. Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease.Am J Cardiol 1981;47:917–922.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clozel, JP., Véniant, M. & Osterrieder, W. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc Drug Ther 4, 731–736 (1990). https://doi.org/10.1007/BF01856562

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01856562

Key Words

Navigation